15.06.2015 Views

G-Protein Coupled Receptors Market

This report on G-protein coupled receptors (GPCRs) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of GPCR assays, cell lines, and consumables and entrants that are planning to invest in the GPCRs market. This report comprises an elaborate executive summary, which includes a market snapshot providing overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global GPCRs market with respect to the leading market segments based on types of products, applications and geographic regions.


This report on G-protein coupled receptors (GPCRs) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of GPCR assays, cell lines, and consumables and entrants that are planning to invest in the GPCRs market. This report comprises an elaborate executive summary, which includes a market snapshot providing overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global GPCRs market with respect to the leading market segments based on types of products, applications and geographic regions.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Transparency <strong>Market</strong><br />

Research<br />

G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong>-Global Industry<br />

Analysis, Size, Share, Growth, Trends and Forecast 2014 –<br />

2022<br />

Published Date<br />

2015-05-29<br />

125 Page Report<br />

Buy Now<br />

Request Sample<br />

Press Release<br />

G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong>-Global Industry<br />

Analysis, Size, Share, Growth, Trends and Forecast 2014 –<br />

2022<br />

Transparency <strong>Market</strong> Research<br />

State Tower,<br />

90, State Street, Suite 700.<br />

Albany, NY 12207<br />

United States<br />

www.transparencymarketresearch.com<br />

sales@transparencymarketresearch.com


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

REPORT DESCRIPTION<br />

This report on G-protein coupled receptors (GPCRs) market studies the current as well as future prospects of the market<br />

globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of GPCR<br />

assays, cell lines, and consumables and entrants that are planning to invest in the GPCRs market. This report comprises an<br />

elaborate executive summary, which includes a market snapshot providing overall information of various segments and<br />

sub-segments included in the study scope. This section also provides overall information and data analysis of the global<br />

GPCRs market with respect to the leading market segments based on types of products, applications and geographic<br />

regions.<br />

Browse Full G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> (GPCRs) <strong>Market</strong> Report With Complete TOC @<br />

http://www.transparencymarketresearch.com/g-protein-coupled-receptors-market.html<br />

The global GPCRs market has been segmented based on of assay type, therapeutic area, and geography. Based on assay<br />

type, the GPCRs market has been categorized into six major segments: cAMP assays, calcium level detection assays,<br />

GTPγS binding assays, reporter gene assays, receptor internalization assays, and cGMP assays. The market for these<br />

segments has been extensively analyzed based on of their effectiveness, usefulness, sales, and geographic presence.<br />

<strong>Market</strong> revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth<br />

rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.<br />

In terms of therapeutic areas, the market has been segmented into seven categories: cardiovascular system, central nervous<br />

system (CNS), respiratory system, immune system, reproductive system, oncology, and others (abdominal, urinary,<br />

orthopedics, etc.). <strong>Market</strong> revenue in terms of USD million for the period between 2012 and 2022 along with the<br />

compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the<br />

base year.<br />

The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that<br />

have strong impact on the GPCRs market currently and could influence the market in future as well. The market<br />

attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in<br />

the market across different geographies. Porter’s Five Forces analysis is also explained in this section to understand the<br />

GPCRs market considering different parameters that have an impact on the sustainability of the companies operating in<br />

Transparency <strong>Market</strong> Research<br />

2


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

the GPCRs market. The competitive scenario among different market players is evaluated through market share analysis<br />

in the competitive landscape section of the report. All these factors would help market players to take strategic decisions<br />

in order to strengthen their positions and expand their shares in the global market.<br />

Browse Full Press Release Report : http://www.transparencymarketresearch.com/pressrelease/g-protein-coupledreceptors-market.htm<br />

Geographically, the GPCRs market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest<br />

of the World (RoW). Major geographic regions have been further divided into major national markets, viz. North America<br />

(the U.S. and Canada), Europe (Germany, the U.K., France, and Rest of Europe), and Asia Pacific (China, Japan, India,<br />

and Rest of Asia Pacific). Moreover, Rest of the World has been further subdivided into three regions: Latin America, the<br />

Middle East, and Africa. <strong>Market</strong> revenue in terms of USD million for the period between 2012 and 2022 along with the<br />

CAGR % from 2014 to 2022 are provided for all the regional and national markets considering 2013 as the base year.<br />

The recommendations section included in the report would assist existing market players in expanding their market shares<br />

and new companies in establishing their presence in the global market. The report also profiles major players in the<br />

GPCRs market based on various attributes such as company overview, financial overview, business strategies, product<br />

portfolio, and recent developments. Major players profiled in this report include Thermo Fisher Scientific, Inc., EMD<br />

(Merck) Millipore, Becton, Dickinson and Company, PerkinElmer, Inc., Cisbio Bioassays, Enzo Life Sciences, Inc.,<br />

DiscoveRx Corporation, Sigma-Aldrich Corporation, QIAGEN N.V., Promega Corporation, Abcam plc, and HD<br />

Biosciences Co. Ltd.<br />

The global GPCRs market is segmented as follows:<br />

GPCRs <strong>Market</strong>, by Assay Type<br />

Calcium Level Detection Assays<br />

GTPγS Binding Assays<br />

cGMP Assays<br />

Reporter Gene Assays<br />

Receptor Internalization Assay<br />

cAMP Assays<br />

GPCRs <strong>Market</strong>, by Therapeutic Area<br />

Transparency <strong>Market</strong> Research<br />

3


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

Cardiovascular System<br />

Central Nervous System<br />

Respiratory System<br />

Immune System<br />

Reproductive System<br />

Oncology<br />

Others<br />

GPCRs <strong>Market</strong>, by Geography<br />

North America<br />

U.S.<br />

Canada<br />

Europe<br />

U.K.<br />

Germany<br />

France<br />

Rest of Europe<br />

Asia Pacific<br />

China<br />

Japan<br />

India<br />

Rest of Asia Pacific<br />

Rest of the World (RoW)<br />

Latin America<br />

Middle East<br />

Transparency <strong>Market</strong> Research<br />

4


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

Africa.<br />

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=b&rep_id=550<br />

Table of Contents<br />

Chapter 1 Introduction<br />

1.1 Report Description<br />

1.2 <strong>Market</strong> Segmentation<br />

1.3 Research Methodology<br />

1.4 Assumptions<br />

Chapter 2 Executive Summary<br />

2.1 <strong>Market</strong> Snapshot: Global G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> (GPCRs) <strong>Market</strong><br />

2.2 Comparative Analysis: Global GPCRs <strong>Market</strong> Revenue, by Geography, 2013 & 2022 (Value %)<br />

Chapter 3 Global G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> (GPCRs) <strong>Market</strong> Overview<br />

3.1 Introduction<br />

3.2 <strong>Market</strong> Drivers<br />

3.2.1 Rising Demand for Advanced/Improved GPCR Assays, Assay Systems and Platforms in Ever Growing Drug<br />

Discovery and ADME Toxicity Studies Worldwide<br />

3.2.2 High Prevalence and Incidence of Cardiovascular, Respiratory, and Reproductive Conditions along with Rising<br />

Occurrence of Cancers and Nervous System Disorders Globally<br />

3.2.3 Increased Government Initiatives and Partnerships/ Collaborations are Likely to Boost Demand for<br />

Technologically Advanced GPCR Assays and Assay Systems Worldwide<br />

3.3 <strong>Market</strong> Restraints<br />

Transparency <strong>Market</strong> Research<br />

5


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

3.3.1 High Cost Involved in the Maintenance of Cell Lines and Costly Equipment and Instruments could Restrain<br />

Demand for GPCR Assays<br />

3.4 <strong>Market</strong> Opportunities<br />

3.4.1 Development of Technologically Advanced GPCR Assays, Assay Systems and Assay Platforms<br />

3.5 Porter’s Five Forces Analysis: Global GPCRs <strong>Market</strong><br />

3.5.1 Bargaining Power of Suppliers<br />

3.5.2 Bargaining Power of Buyers<br />

3.5.3 Threat of Substitutes<br />

3.5.4 Threat of New Entrants<br />

3.5.5 Competitive Rivalry<br />

3.6 Value Chain Analysis: GPCRs <strong>Market</strong><br />

3.7 <strong>Market</strong> Attractiveness Analysis: Global GPCRs <strong>Market</strong>, by Geography<br />

3.8 Competitive Landscape<br />

3.8.1 <strong>Market</strong> Share Analysis, by Key Players: Global GPCRs <strong>Market</strong>, 2013 (Value %)<br />

Chapter 4 Global G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> (GPCRs) <strong>Market</strong>, by Assay Type<br />

4.1 Introduction<br />

4.1.1 Global GPCRs <strong>Market</strong> Revenue, by Assay Type, 2012 – 2022 (USD Million)<br />

4.1.2 Comparative Analysis: Global GPCRs <strong>Market</strong> Revenue, by Assay Type, 2013 & 2022 (Value %)<br />

4.2 Calcium Level Detection Assays<br />

4.2.1 Global Calcium Level Detection Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

4.3 GTPγS Binding Assays<br />

4.3.1 Global GTPγS Binding Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

4.4 cGMP Assays<br />

Transparency <strong>Market</strong> Research<br />

6


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

4.4.1 Global cGMP Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

4.5 Reporter Gene Assays<br />

4.5.1 Global Reporter Gene Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

4.6 Receptor Internalization Assays<br />

4.6.1 Global Receptor Internalization Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

4.7 cAMP Assays<br />

4.7.1 Global cAMP Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

Chapter 5 Global G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> (GPCRs) <strong>Market</strong>, by Therapeutic Areas<br />

5.1 Introduction<br />

5.1.1 Global GPCRs <strong>Market</strong> Revenue, by Therapeutic Areas, 2012 – 2022 (USD Million)<br />

5.1.2 Comparative Analysis: Global GPCRs <strong>Market</strong> Revenue, by Therapeutic Areas, 2013 & 2022 (Value %)<br />

5.2 Cardiovascular System<br />

5.2.1 Global GPCR Assays in Cardiovascular Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

5.3 Central Nervous System (CNS)<br />

5.3.1 Global GPCR Assays in CNS Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

5.4 Respiratory System<br />

5.4.1 Global GPCR Assays in Respiratory Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

5.5 Immune System<br />

5.5.1 Global GPCR Assays in Immune System Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

5.6 Reproductive System<br />

5.6.1 Global GPCR Assays in Reproductive System Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

5.7 Oncology<br />

5.7.1 Global GPCR Assays in Oncology Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

Transparency <strong>Market</strong> Research<br />

7


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

5.8 Other Therapeutic Areas<br />

5.8.1 Global GPCR Assays in Other Therapeutic Areas <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

Chapter 6 Global G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> (GPCRs) <strong>Market</strong>, by Geography<br />

6.1 Introduction<br />

6.1.1 Global GPCRs <strong>Market</strong> Revenue, by Geography, 2012 – 2022 (USD Million)<br />

6.2 North America<br />

6.2.1 North America GPCRs <strong>Market</strong> Revenue, by Country, 2012 – 2022 (USD Million)<br />

6.2.2 United States<br />

6.2.2.1 United States GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.2.3 Canada<br />

6.2.3.1 Canada GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.3 Europe<br />

6.3.1 Europe GPCRs <strong>Market</strong> Revenue, by Country, 2012 – 2022 (USD Million)<br />

6.3.2 The United Kingdom<br />

6.3.2.1 United Kingdom GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.3.3 Germany<br />

6.3.3.1 Germany GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.3.4 France<br />

6.3.4.1 France GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.3.5 Rest of Europe<br />

6.3.5.1 Rest of Europe GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.4 Asia Pacific<br />

6.4.1 Asia Pacific GPCRs <strong>Market</strong> Revenue, by Country, 2012 – 2022 (USD Million)<br />

Transparency <strong>Market</strong> Research<br />

8


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

6.4.2 China<br />

6.4.2.1 China GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.4.3 Japan<br />

6.4.3.1 Japan GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.4.4 India<br />

6.4.4.1 India GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.4.5 Rest of Asia Pacific<br />

6.4.5.1 Rest of Asia Pacific GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.5 Rest of the World (RoW)<br />

6.5.1 Rest of the World GPCRs <strong>Market</strong> Revenue, by Geography, 2012 – 2022 (USD Million)<br />

6.5.2 Latin America<br />

6.5.2.1 Latin America GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.5.3 Middle East<br />

6.5.3.1 Middle East GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

6.5.4 Africa<br />

6.5.4.1 Africa GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

Chapter 7 Recommendations<br />

7.1 Develop Technologically Advanced GPCR Assays, Assay Systems and Platforms to Create Future Growth<br />

Opportunities<br />

7.2 Target Emerging Economies of the World for Higher Benefits<br />

7.3 Collaborate to Strengthen <strong>Market</strong> Presence<br />

Chapter 8 Company Profiles<br />

Transparency <strong>Market</strong> Research<br />

9


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

8.1 Abcam plc<br />

8.1.1 Company Overview<br />

8.1.2 Financial Overview<br />

8.1.3 Product Portfolio<br />

8.1.4 Business Strategies<br />

8.1.5 Recent Developments<br />

8.2 Becton, Dickinson and Company<br />

8.2.1 Company Overview<br />

8.2.2 Financial Overview<br />

8.2.3 Product Portfolio<br />

8.2.4 Business Strategies<br />

8.2.5 Recent developments<br />

8.3 Cisbio Bioassays<br />

8.3.1 Company Overview<br />

8.3.2 Financial Overview<br />

8.3.3 Product Portfolio<br />

8.3.4 Business Strategies<br />

8.3.5 Recent Developments<br />

8.4 DiscoveRx Corporation<br />

8.4.1 Company Overview<br />

8.4.2 Financial Overview<br />

8.4.3 Product Portfolio<br />

8.4.4 Business Strategies<br />

8.4.5 Recent Developments<br />

Transparency <strong>Market</strong> Research<br />

10


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

8.5 EMD Millipore Corporation<br />

8.5.1 Company Overview<br />

8.5.2 Financial Overview<br />

8.5.3 Product Portfolio<br />

8.5.4 Business Strategies<br />

8.5.5 Recent Developments<br />

8.6 Enzo Life Sciences, Inc.<br />

8.6.1 Company Overview<br />

8.6.2 Financial Overview<br />

8.6.3 Product Portfolio<br />

8.6.4 Business Strategies<br />

8.6.5 Recent Developments<br />

8.7 HD Biosciences Co. Ltd.<br />

8.7.1 Company Overview<br />

8.7.2 Financial Overview<br />

8.7.3 Product Portfolio<br />

8.7.4 Business Strategies<br />

8.7.5 Recent Developments<br />

8.8 PerkinElmer, Inc.<br />

8.8.1 Company Overview<br />

8.8.2 Financial Overview<br />

8.8.3 Product Portfolio<br />

8.8.4 Business Strategies<br />

8.8.5 Recent Developments<br />

Transparency <strong>Market</strong> Research<br />

11


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

8.9 Promega Corporation<br />

8.9.1 Company Overview<br />

8.9.2 Financial Overview<br />

8.9.3 Product Portfolio<br />

8.9.4 Business Strategies<br />

8.9.5 Recent Developments<br />

8.10 QIAGEN<br />

8.10.1 Company Overview<br />

8.10.2 Financial Overview<br />

8.10.3 Product portfolio<br />

8.10.4 Business Strategies<br />

8.10.5 Recent Developments<br />

8.11 Sigma-Aldrich Corporation<br />

8.11.1 Company Overview<br />

8.11.2 Financial Overview<br />

8.11.3 Product Portfolio<br />

8.11.4 Business Strategies<br />

8.11.5 Recent Developments<br />

8.12 Thermo Fisher Scientific, Inc.<br />

8.12.1 Company Overview<br />

8.12.2 Financial Overview<br />

8.12.3 Product portfolio<br />

8.12.4 Business Strategies<br />

8.12.5 Recent Developments<br />

Transparency <strong>Market</strong> Research<br />

12


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

List of Figures<br />

FIG. 1 G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> (GPCRs): <strong>Market</strong> Segmentation<br />

FIG. 2 Global GPCRs <strong>Market</strong> Revenue, by Assay Type, 2013 (USD Million)<br />

FIG. 3 Global GPCRs <strong>Market</strong> Revenue, by Therapeutic Areas, 2013 (USD Million)<br />

FIG. 4 Comparative Analysis: Global GPCRs <strong>Market</strong> Revenue, by Geography, 2013 & 2022 (Value %)<br />

FIG. 5 Porter’s Five Forces Analysis: Global GPCRs <strong>Market</strong><br />

FIG. 6 Value Chain Analysis: Global GPCRs <strong>Market</strong><br />

FIG. 7 <strong>Market</strong> Attractiveness Analysis: Global GPCRs <strong>Market</strong>, by Geography, 2013<br />

FIG. 8 <strong>Market</strong> Share Analysis, by Key Players: Global GPCRs <strong>Market</strong>, 2013 (Value %)<br />

FIG. 9 Comparative Analysis: Global GPCRs <strong>Market</strong> Revenue, by Assay Type, 2013 & 2022 (Value %)<br />

FIG. 10 Global Calcium Level Detection Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 11 Global GTPγS Binding Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 12 Global cGMP Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 13 Global Reporter Gene Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 14 Global Receptor Internalization Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 15 Global cAMP Assays <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 16 Comparative Analysis: Global GPCRs <strong>Market</strong> Revenue, by Therapeutic Areas, 2013 & 2022 (Value %)<br />

FIG. 17 Global GPCR Assays in Cardiovascular Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 18 Global GPCR Assays in CNS Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 19 Global GPCR Assays in Respiratory Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 20 Global GPCR Assays in Immune System Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 21 Global GPCR Assays in Reproductive System Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 22 Global GPCR Assays in Oncology Therapeutics <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

Transparency <strong>Market</strong> Research<br />

13


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

FIG. 23 Global GPCR Assays in Other Therapeutic Areas <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 24 United States GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 25 Canada GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 26 United Kingdom GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 27 Germany GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 28 France GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 29 Rest of Europe GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 30 China GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 31 Japan GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 32 India GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 33 Rest of Asia Pacific GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 34 Latin America GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 35 Middle East GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 36 Africa GPCRs <strong>Market</strong> Revenue, 2012 – 2022 (USD Million)<br />

FIG. 37 Abcam plc: Annual Revenue, 2011 – 2013 (USD Million)<br />

FIG. 38 BD Biosciences: Annual Revenue, 2011 – 2013 (USD Million)<br />

FIG. 39 EMD Millipore Corporation: Annual Revenue, 2011 – 2013 (USD Million)<br />

FIG. 40 Enzo Life Sciences, Inc.: Annual Revenue, 2011 – 2013 (USD million)<br />

FIG. 41 PerkinElmer, Inc.: Annual Revenue, 2011 – 2013 (USD Million)<br />

FIG. 42 QIAGEN: Annual Revenue, 2011 – 2013 (USD Million)<br />

FIG. 43 Sigma-Aldrich Corporation: Annual Revenue, 2011 – 2013 (USD million)<br />

FIG. 44 Thermo Fisher Scientific, Inc.: Annual Revenue, 2011 – 2013 (USD Million)<br />

List of Tables<br />

Transparency <strong>Market</strong> Research<br />

14


G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> <strong>Market</strong><br />

TABLE 1 <strong>Market</strong> Snapshot: Global G-<strong>Protein</strong> <strong>Coupled</strong> <strong>Receptors</strong> (GPCRs) <strong>Market</strong><br />

TABLE 2 Global GPCRs <strong>Market</strong> Revenue, by Assay Type, 2012 – 2022 (USD Million)<br />

TABLE 3 Global GPCRs <strong>Market</strong> Revenue, by Therapeutic Areas, 2012 – 2022 (USD Million)<br />

TABLE 4 Global GPCRs <strong>Market</strong> Revenue, by Geography, 2012 – 2022 (USD Million)<br />

TABLE 5 North America GPCRs <strong>Market</strong> Revenue, by Country, 2012 – 2022 (USD Million)<br />

TABLE 6 Europe GPCRs <strong>Market</strong> Revenue, by Country, 2012 – 2022 (USD Million)<br />

TABLE 7 Asia Pacific GPCRs <strong>Market</strong> Revenue, by Country, 2012 – 2022 (USD Million)<br />

TABLE 8 Rest of the World GPCRs <strong>Market</strong> Revenue, by Geography, 2012 – 2022 (USD Million)<br />

About Us<br />

Transparency <strong>Market</strong> Research is a global market intelligence company, providing global business information reports and<br />

services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for<br />

thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants,<br />

who use proprietary data sources and various tools and techniques to gather, and analyze information.<br />

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest<br />

trends and information. With a broad research and analysis capability, Transparency <strong>Market</strong> Research employs rigorous<br />

primary and secondary research techniques in developing distinctive data sets and research material for business reports.<br />

Contact<br />

Mr.Nachiket<br />

90 State Street,<br />

Suite 700,<br />

Albany<br />

NY - 12207<br />

United States<br />

Tel: +1-518-618-1030<br />

USA - Canada Toll Free 866-552-3453<br />

Email: sales@transparencymarketresearch.com<br />

Website: http://www.transparencymarketresearch.com/<br />

Transparency <strong>Market</strong> Research<br />

15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!